ASX:EVE EVE Health Group (EVE) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About EVE Health Group Stock (ASX:EVE) Get EVE Health Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.21 million shsAverage VolumeN/AMarket CapitalizationA$5.27 millionP/E RatioN/ADividend Yield8.15%Price TargetN/AConsensus RatingN/A Company Overview Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia. Read More Receive EVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EVE Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVE Stock News HeadlinesEVE Health Group Full Year 2025 Earnings: AU$0.011 loss per share (vs AU$0.012 loss in FY 2024)August 31, 2025 | finance.yahoo.comEVE Health Group Releases 2025 Corporate Governance StatementAugust 29, 2025 | tipranks.comThe dollar is failing – here’s your escapeSilver’s 100X Run Is Coming? All gold bull markets follow the same pattern. First, gold moves up. Then major gold miners catch a bid. That’s where we are today. The next leg – or Phase Two and the move you do NOT want to miss – is when silver plays catch-up to the fast climbing gold price. Garrett’s top 7 silver picks are primed for liftoff.September 18 at 2:00 AM | Golden Portfolio (Ad)EVE Health Group Advances with First Commercial Order for Libbo™August 20, 2025 | msn.comEVE Health Group Advances with First Commercial Order for Libbo™August 20, 2025 | msn.comEVE Health Group Secures Regulatory Approval for Australian Launch of Key ProductsJuly 20, 2025 | tipranks.comNew HSE guidelines named after Eve Cleary aim to prevent fatal blood clots in future patientsJuly 19, 2025 | msn.comEVE Health Group Advances in Women’s Health with First Order of Dyspro™July 6, 2025 | tipranks.comSee More Headlines EVE Stock Analysis - Frequently Asked Questions What other stocks do shareholders of EVE Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that EVE Health Group investors own include Adelong Gold (DDD) and Hess (HES). Industry, Sector and Symbol Stock ExchangeASX SectorConsumer Defensive Industry Packaged Foods Sub-IndustryN/A Current SymbolASX:EVE CIKN/A Webwww.eveinvestments.com.au Phone61 8 6465 5500FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$1.55 million Net Margins-89.09% Pretax MarginN/A Return on Equity-111.83% Return on Assets-29.61% Debt Debt-to-Equity Ratio6.12 Current Ratio1.94 Quick Ratio1.72 Sales & Book Value Annual SalesA$2.13 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.50 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares5,270,000,000Free FloatN/AMarket CapA$5.27 million OptionableNot Optionable Beta1.00 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (ASX:EVE) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EVE Health Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EVE Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
